Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-013077·Harmony Biosciences Holdings, Inc.
Schedule 13G ownership disclosure
Harmony Biosciences Holdings Inc
Common Stock, $0.00001 par value per share · CUSIP: 413197104
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Valor IV Pharma Holdings, LLC
Shares: 6,618,033.00 · Class: 11.6%
- Valor Equity Partners IV L.P.
Shares: 5,117,088.00 · Class: 9.0%
- Valor Equity Partners IV-A L.P.
Shares: 281,739.00 · Class: 0.5%
- Valor Equity Partners IV-B L.P.
Shares: 1,219,206.00 · Class: 2.1%
- Valor Equity Associates IV L.P.
Shares: 6,618,033.00 · Class: 11.6%
- Valor Equity Capital IV LLC
Shares: 6,618,033.00 · Class: 11.6%
- Valor Management L.P.
Shares: 6,618,033.00 · Class: 11.6%
- Antonio J. Gracias
Shares: 6,654,747.00 · Class: 11.7%
- Juan A. Sabater
Shares: 6,644,257.00 · Class: 11.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-013077
- Form type
- SCHEDULE 13G/A
- Filer
- Harmony Biosciences Holdings, Inc.
- CIK
- CIK 1802665
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership